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ABSTRACT
Objective: Renal stone disease has become an important clinical condition worldwide, and it results from a combination of several factors which 
are biochemical, epidemiologic, and genetic in origin. Preventive measures are very important concerning stone disease and these measures greatly 
depend on the type of stones. Performing a metabolic evaluation of stone patients to identify metabolic abnormality, if any, and treating the same helps 
reduce the recurrence of stones. To identify and correct the metabolic risk factors of patients presenting with either recurrent, bilateral, or multiple 
stones and thereby reduce the recurrence of stones.
Methods: A hospital-based prospective observational study, including collection of essential data of 100 patients and analyzing them for any metabolic 
abnormality.
Results: Out of the 100 patients, 73 were males and 27 were females. The frequency of stone formation was high in the age group 51-60, even 
though age is not a significant factor. Only 55 patients underwent metabolic evaluation, in which 23 patients (41.8%) had a metabolic abnormality. 
The common abnormality found in this geographical area was hyperuricosuria (29.1%) followed by hypercalciuria (7.3%). Hypercalciuria was not 
statistically significant, but hyperuricosuria and acidic urine pH were significant factors that contribute to stone formation.
Conclusion: Metabolic evaluation is a must for renal stone patients which greatly help reduce the risk of stone recurrence. Hyperuricemia was 
observed to be the major abnormality followed by hypercalciuria. Acidic urine pH and low urine volume were other significant risk factors.
Keywords: Nephrolithiasis, Metabolic evaluation, Hyperuricosuria, Hypercalciuria.
INTRODUCTION
Renal calculus disease or nephrolithiasis is an important clinical 
condition which may result in hematuria and severe abdominal pain. 
Stones, when bilateral, can obstruct urinary flow which sometimes 
can lead to end stage renal disease, but nephrolithiasis is not an 
essential risk factor for incident chronic kidney disease [1]. A kidney 
stone, also called a renal calculus or nephrolith, is a mass of crystals 
which when formed together, create a hard lump in one or both the 
kidneys. It is formed from minerals present in the urine and can be 
present for a long time without causing any problems or symptoms. 
When they move, they cause discomfort and severe pain (renal colic) 
in the back or abdomen that radiates to the groin. Other associated 
symptoms include vomiting, fever, blood in urine, pus in urine, and 
painful urination. The majority of renal stones can pass out of the body 
in the urine without any help, whereas some require intervention to 
remove them [2].
Stone disease has become a relatively common disorder, and its 
prevalence is greatly increasing worldwide. The diagnosis of renal 
stones is usually based on the symptoms, urine testing, and also medical 
imaging. Blood tests may also be useful. There are different types of 
stones based on their composition: Calcium oxalate (80%), calcium 
phosphate (5-10%), uric acid (5-10%), oxalate (5%), cysteine (1-2%), 
and struvite stones (10-15%) [3]. High dietary intake of animal protein, 
sodium, refined sugars, fructose, and high cola drinks can greatly 
contribute to the increased risk of developing renal calculi. Hereditary 
factors are also related to stone formation. People with certain medical 
conditions, such as hypertension, diabetes, gout, kidney infection, and 
those who take certain medications or supplements are at risk for renal 
stones [4].
Metabolic evaluation of renal stones, especially bilateral, multiple, 
or recurrent stones have become an important part of this clinical 
condition as it helps to identify the major metabolic abnormalities 
contributing to the formation of stones. It has been established from 
various studies that a stone former would have one or more metabolic 
abnormalities contributing to stone formation, which when treated 
properly can greatly help reduce the recurrence of stones. Reliable 
stone analysis and basic metabolic evaluation are greatly recommended 
in all the patients after stone passage. Metabolic screening allows 
diet related stone identification, points out stone risk factors, and 
identifies patient’s comorbidity. People who have significant metabolic 
abnormalities are more at risk for stone formation, whereas people who 
frequently get stones are observed to have more significant metabolic 
abnormality [5].
Metabolic evaluation usually includes tests for serum calcium, 
phosphorus, uric acid, creatinine, blood urea nitrogen (BUN), 
electrolytes, stone analysis, and urinalysis, including urine pH. Apart 
from this, 24-hrs urine collections on a random diet with components 
of urine such as urine volume, calcium, sodium, creatinine, citrate, 
uric acid, and oxalate are also an essential part of metabolic 
evaluation [6].
The general preventive measures for renal calculi includes increasing 
the fluid intake to more than 3 litres/day, reducing the intake of animal 
proteins, dairy products, and purine-rich foods, maintaining a healthy 
weight, adequate fruits, vegetables and fiber intake, regular exercise, 
and making self-free from other medical conditions such as diabetes, 
hypertension, gout, and hyperparathyroidism [2].
Here, in this geographical area, renal stone patients are common 
and there are plenty of them consulting with complaints of severe 
abdominal pain and other symptoms. In this study, the major focus 
was given to patients who were diagnosed with bilateral, recurrent, 
and multiple stones, and single stone formers were excluded as this 
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study was conducted to evaluate the metabolic abnormalities related 
to stone formation. Single stones occur as a result of either structural 
abnormality of the urinary tract or lifestyle pattern of the patients 
such as low water intake, high protein intake, occupation in hot 
places, and obesity. Single stone usually is not related to any metabolic 
abnormality. Any metabolic abnormality in an individual can result 
in staghorn calculi or multiple/bilateral stone. If this abnormality 
is left untreated, it can lead to recurrence of stones. The common 
metabolic abnormalities occurring in such patients are hypercalciuria, 
hyperuricosuria, hyperoxaluria, and hypocitraturia. An individual can 
have one or more than one metabolic abnormality. Thus, evaluation of 
the metabolic abnormality and treating the same can greatly reduce the 
incidence of stones and improve the quality of life of the patients.
METHODS
The study was conducted over a time of 7 months, starting from January 
to July 2016, in the Kovai Medical Center and Hospital, Coimbatore, 
after ethical approval has been obtained from the Ethics Committee of 
the hospital in the month of January 2016. This was a hospital-based 
prospective observational study, enrolling 100 patients presenting with 
bilateral, multiple, or recurrent stones, to the Department of Urology 
of the hospital. The main tool used to collect the patient details was a 
properly designed data collection form which included variables such 
as age, sex, body mass index (BMI), dietary pattern, family history, past 
history, average water intake, alcohol intake, type of stone, diagnostic 
tests, 24 hrs urine analysis components, serum calcium, serum uric 
acid, serum creatinine, random blood sugar (RBS), and BUN and also 
treatment methods used. Out of the 100 patients selected, 73 were 
males and 27 were females. 55 patients had bilateral stones and around 
23 presented with recurrence.
The inclusion criteria were patients having bilateral/multiple stones 
and recurrent stone formers, whereas single stone, infection stones, 
and first-time stone formers (FTSFs) were excluded.
SPSS software was used to statistically analyze the data, and the main 
statistical method used to find out the significance of each variable as 
risk for stone formation was Chi-square test. A p<0.05 was considered 
significant. Descriptive statistics was also used to obtain the variable 
versus percent graphs.
A wide literature survey was also conducted to obtain literatures 
relating and supporting the present study.
RESULTS
A total of 100 patients who came with either bilateral, multiple, or 
recurrent renal stones to the Urology Department of KMCH were 
included in this prospective study, which was aimed to find out 
the common metabolic abnormality occurring in patients of this 
geographical region. The included variables were considered to be 
significant factors for the formation of stones if p<0.05.
Out of these 100 patients studied in total, 73 were males and 27 were 
females. Thus, it was observed that in this study of small population, the 
frequency of stone formation was very high in males (73%) compared 
to females (27%) (Table 1). The frequency of stone formation was high 
in the age group 51-60. The overall age range for stone formation in this 
study was observed to be 31-60 years (Table 2), and the mean age was 
observed to be 45.71±14.20.
Abdominal pain was the major symptom along with fever and back pain 
among the patients. High BMI is assumed to be a risk factor for stone 
formation as 48% were belonging to the category of overweight and 
7% were obese (Fig. 1).
About 55% patients presented with bilateral stones and 12% with 
bilateral-recurrent stones (Table 3). Stone recurrence was present 
in around 28% patients showing that the FTSF was prone to the risk 
of recurrence. Thus, it is a good opinion to perform the metabolic 
evaluation in FTSF as well to reduce the recurrence of stones.
The majority of patients were non-vegetarians, i.e., 94% of the study 
population (n=100) as shown in Table 4. This shows that dietary 
pattern has a major role in stone formation. The individuals who were 
found to consume a high quantity of protein foods were at high risk. 
Thus, diet modification is essential. Average water intake was <2 liters/
day for majority, i.e., 73 patients (Table 5), which concluded that low 
water intake is another major risk factor for stone.
Several blood tests were performed to help detect the metabolic 
abnormality if any. Although urine analysis was not done for the entire 
population, it was performed in few individuals who had staghorn and 

















Table 3: Distribution of stone type in the study 
population (n=100)




B/L and recurrent 12 (12.0)
B/L and multiple 10 (10.0)
Recurrent and multiple 3 (3.0)
B/L, recurrent and multiple 2 (2.0)
Total 100 (100.0)
Fig. 1: A plot of weight in the study population (n=100)
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multiple calculi. The main urine analysis components tested were urine 
volume, urine pH, urine calcium, and urine uric acid. Patients who had 
acidic urine had a greater frequency of stone formation concluding that 
stone formation is greatly favored in acidic condition (Fig. 2). Thus, 
urine pH is also a risk factor and also it was statistically proven to be 
a significant factor (p=0.05 in n=100) as shown in Table 6. The urine 
calcium test was not performed in majority (94%), and in the evaluated 
6 patients, 2 were normal, 1 was low, and 3 were high (Fig. 3). In urine 
uric acid test, only 2% had increased levels (Fig. 4).
The individuals who showed an increased level of serum uric acid and 
calcium were not subject to urine calcium and uric acid test as the 
metabolic abnormality is already known.
Test for serum calcium was not done for 58% as there did not arise any 
need, it was normal for 36%, low in 4%, and high in 2% patients (Fig. 5), 
and statistically, it was proven to be a significant factor with stone 
formation in this small population under study (p=0.000 in n=100 and 
p=0.002 in n=55) as shown in Tables 6 and 7. Test for serum uric acid 
was not performed in 50 patients, it was normal in 36 patients, and high 
in 14 patients (Fig. 6) which showed that abnormal (increased) uric 
acid levels are statistically significant risk factor for stone formation 
(p<0.001 in n=100 and p<0.001 in n=55) as in Tables 6 and 7.
The patients RBS test when performed showed that 27% had high 
levels and 3 had greatly increased levels of blood glucose (Fig. 7). RBS 
was also observed to be a statistically significant factor for renal calculi 





Table 5: Distribution of average water intake in the study 
population (n=100)
Average water intake Frequency (%)
<2 L 73 (73.0)
2-3 L 27 (27.0)
Total 100 (100.0)











Urine uric acid 0.182
Serum calcium <0.001
Serum uric acid <0.001
RBS 0.028
Serum creatinine 0.040
p<0.05 significant. RBS: Random blood sugar











p<0.05 significant. RBS: Random blood sugar
Fig. 2: Plot of urine pH (n=100)
Fig. 3: Plot of urine calcium (n=100)
Fig. 4: Plot of urine uric acid (n=100)
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(p=0.028 in n=100) as in Table 6. Serum creatinine tests revealed that 
the creatinine level was high in 26% and greatly increased in 12 patients, 
whereas it was normal in 61% (Fig. 8). Creatinine was also a statistically 
significant factor (p=0.040 in n=100) related to renal stones as shown 
in Table 6. BUN was abnormal in 12 patients (high in 11 and low in 1), 
normal in 21, and the test not performed in 67 patients (Fig. 9). Finally, 
it was observed that BUN also has significance with the stone formation 
(p=0.03 in n=100 and p=0.052 in n=55) shown in Tables 6 and 7.
The major diagnostic tests done were computed tomography (CT) scan 
and ultrasound (US) scan and also a combination of US and CT scan 
was done for better and accurate stone confirmation results. The major 
treatment option in our hospital was a combination of ureterorenoscopy 
(URS)+extracorporeal shock wave lithotripsy (ESWL). URS alone was 
also a commonly used treatment option which gave satisfactory results 
and improved the quality of life of the patient.
Metabolic evaluation was done for 55 patients in the study population, 
and 23 out of this 55 evaluated were found to have a metabolic 
abnormality, whereas 32 were free from any abnormalities (Table 8). 
Out of this 55 patients, 40 (72.7%) were males and 15 (27.3%) 
were females (Table 9). 23 patients (41.8%) had an abnormality in 
metabolism (n=55). Metabolic abnormality was found in the age 
group 31-60 (Fig. 10). However, age was not a factor for metabolic 
abnormality. Gender did not also have significant difference (p=0.734 
in n=100 and p=0.435 in n=55). Uric acid levels were high in 16 patients 
(29.1%) as shown in Fig. 11, calcium levels high in 4 patients (7.3%) as 
in Table 10, and creatinine was high in 21 patients (38.2%) as shown 
in Table 11. In the evaluated population, urine volume was found to be 
low (≤1500 ml) in 25.5% and very low, i.e., <1000 ml, in 5.5% of the 
patients (Fig. 12). Urine pH test was not done in 16.4% of the evaluated 
patients; it was acidic in 69.1%, neutral in 10.9%, and alkaline in 3.6% 
of the patients (Fig. 13).
Chi-square test was done to find out the significance of certain 
factors such as sex, diet, alcohol intake, weight, family history, 
urine volume, urine pH, calcium, uric acid, RBS, and creatinine 
with stone formation. The test was individually applied to both 
the populations, i.e., n=100 as well as n=55. It was observed that 
sex, weight, diet, alcohol intake, and urine volume did not have a 
significant relationship with stone formation in the total population 
(n=100) studied. However, factors such as family history, urine pH, 
serum calcium, serum uric acid, serum creatinine, and RBS were 
proved to be statistically significant factors of stone formation. Uric 
acid abnormality was found to be the major metabolic abnormality 
followed by calcium abnormality. Urine pH was also found to be a 
significant risk factor (p=0.050). Increased RBS and BUN also had 
contribution to stone formation (Table 6).
When Chi-square test was applied to the metabolically evaluated 
population, n=55, it was observed that increased uric acid was the 
major metabolic abnormality followed by increased calcium and 
decreased urine volume (Table 7). Therefore, it was found out from the 
study that hyperuricosuria, hypercalciuria, decreased urine volume, 
and acidic urine pH were the significant metabolic risk factors in the 
population evaluated.
Fig. 5: Plot of serum calcium (n=100)
Fig. 6: Plot of serum uric acid (n=100)
Fig. 7: Plot of RBS (n=100)
Fig. 8: Plot of serum creatinine (n=100)
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DISCUSSION
Nephrolithiasis or stone disease has become a relatively common 
disorder, and its prevalence is greatly increasing worldwide. Here, in 
this geographical area, renal stone patients are common, and we have 
plenty of them consulting the urology department of our hospital. In 
this study, the major focus was given to patients who were diagnosed 
with bilateral, recurrent, and multiple stones, and single stone formers 
were excluded as this study was conducted to evaluate the metabolic 
abnormalities related to stone formation. Single stones occur as a result 
of either structural abnormality of the urinary tract or lifestyle pattern 
of the patients such as low water intake, high protein intake, occupation 
in hot places, and obesity. Single stone usually is not related to any 
metabolic abnormality.
Any metabolic abnormality in an individual can result in staghorn 
calculi or multiple/bilateral stone. If this abnormality is left untreated, it 
can lead to recurrence of stones. The common metabolic abnormalities 
occurring in such patients are hypercalciuria, hyperuricosuria, 
hyperoxaluria, and hypocitraturia. An individual can have one or more 
than one metabolic abnormality. Thus, evaluation of the metabolic 
abnormality and treating the same can greatly reduce the incidence of 
stones.
In case of single stone or FTSF, if the stone is staghorn calculi, it is always 
good to perform a metabolic evaluation, so as to help the individual 
cope up with the risk of further recurrences in the future. This fact is 
supported by the study conducted by Joshi et al. [7], in which he finally 
concluded that comprehensive metabolic evaluation is required even 
in FTSF. By observing the etiology of stone formation, we can greatly 
decrease the possibility of recurrent stone formation with medical 
therapy. Thus, it is possible to reduce the morbidity, mortality, and cost 
associated with renal stones.
All stone forming patients should have a thorough history and physical 
examination, where any previous history of stone disease and treatment 
Table 8: Metabolic evaluation done in the study 
population (n=100)
Metabolic evaluation Frequency (%)
Not evaluated 45 (45.0)
Metabolic abnormality present 23 (23.0)
No metabolic abnormality 32 (32.0)
Total 100 (100.0)






Table 10: Distribution of calcium level in the evaluated 
patients (n=55)
Calcium Frequency (%)





Table 11: Distribution of creatinine in the evaluated 
patients (n=55)
Creatinine Frequency (%)




Fig. 9: Plot of BUN (n=100)
Fig. 10: Plot of age in n=55
Fig. 11: Plot of uric acid in n=55
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along with family history, if any, should be documented. In this study, 
it was observed that family history did have a significant relationship 
with stone formation. Thus, it is concluded that there are chances of 
calculi formation in first or second generations of the stone former.
In this study, 48% patients were overweight, whereas 7% were obese, 
which shows that increased body mass can be another causative factor 
for renal stones. Although weight was not proved to be statistically 
significant, it could be a contributing factor toward stone formation. 
Moreover, this was in accordance with the large prospective study 
conducted by Taylor et al. [8], in which it was concluded that obesity/
weight gain can increase the risk of renal stone formation and that the 
magnitude of increased risk may be greater in women than in men (in 
the present study, the magnitude of increased risk was greater in men). 
Weight gain since early adulthood was associated with an increased risk 
of incident kidney stone formation in both men and women. Another 
study conducted by Charkhchian et al. [9] also revealed that higher BMI 
may be a risk factor for nephrolithiasis.
Shekarriz and Marshall [10] in his study suggested that laboratory 
evaluation should include urine analysis and culture; stone analysis 
is an integral part of evaluation. Some authors recommend metabolic 
evaluation in all patients even those with a single stone episode, 
whereas others suggest that single stone formers without any risk 
factors do not require further investigations. In patients with high 
risk for stone recurrence or recurrent stone former, a more detailed 
evaluation is recommended where additional 24 hrs urine collection 
with calcium and uric acid tests should be done.
Treatment of renal stones is of much importance, and medical therapy 
helps reduce recurrence of stones significantly. Medical expulsive 
therapy is used for spontaneous stone passage, and it has been provided 
in our hospital. In cases where medical expulsive therapy fails to pass 
the stone, other treatment opinions such as URS, ESWL, percutaneous 
nephrolithotomy (PCNL), and surgery are taken into consideration. 
Usually for patients presenting hyperuricosuria, allopurinol, which is a 
xanthine oxidase inhibitor, is the drug of choice and for those presenting 
hypercalciuria, treatment with thiazides are preferred. Appropriate 
antibiotic therapy is also prescribed in cases which show stones with 
infection.
The present study concluded that hyperuricosuria, low urine volume, 
and acidic urine pH were significant risk factors of stone formation, 
and the results of this study perfectly complies with the former study 
conducted by Xu et al. [11], in which he explained that low urine volume, 
hyperuricosuria, and abnormally acidic urine pH leads to formation 
of uric acid stone. Hyperuricosuria can occur as a result of intake of 
purine-rich diet, low water intake, and acidic urine pH. Low urine pH is 
the principal determinant in uric acid crystallization. In such condition, 
the main aim of treatment is to increase the solubility of uric acid in 
urine and to reduce its concentration by urinary alkalization using 
sodium or potassium alkali. The consumption of animal protein should 
also be greatly reduced.
Renal stones are usually preventable. In a study conducted by Goldfarb 
and Arowojolu [12], it was said that, to maximize the efficacy of 
preventive regimens and to obtain a cost-effective treatment, the 
appropriate data should be collected (past medical history, family 
history, social history, occupation, activities, and diet). Laboratory 
evaluation of serum chemistries, urine analysis, and 24 hrs urine 
collections are most appropriate for recurrent stone formers. Past 
history and family history details were collected and observed in the 
present study; family history was found to be significant, whereas 
history did not show to be significant. Hypertension and diabetes 
are often associated with metabolic syndrome, which in turn is 
associated with an increased risk of uric acid stone formation caused 
by the associated unduly acid urine caused by insulin resistance. In the 
present study, it was observed that diabetes and hypertension were 
predominant past medical history, and thus, they maybe a contributor 
to stone formation. Talking about diet, although majority of the study 
population was non-vegetarians (94%), a non-vegetarian dietary 
pattern did not prove to be a statistically significant risk factor as per 
Chi-square test. However taking in consideration the total population, it 
is suggested that high intake of animal protein can lead to significantly 
increased the risk for stone formation.
It was also found out in this study that complete metabolic evaluation 
was not performed in the majority of the patients, which was similar to a 
study conducted by Krepinsky et al. [13], in which he concluded that the 
majority of patients presenting with recurrent stones do not actually 
undergo appropriate metabolic investigations. The metabolically 
evaluated patients (n=55) of this present study were also not completely 
evaluated as 24 hrs urine analysis was not compulsorily performed by 
the physicians. Only certain variables such as serum calcium, serum uric 
acid, urine pH, RBS, creatinine, and BUN were performed, and patients 
who met these tests were considered metabolically evaluated. In certain 
cases, where blood tests did not reveal any major abnormality, 24 hrs 
urine collections were made and test for urine volume, urine pH, urine 
calcium, urine uric acid, and urine creatinine was investigated. These 
patients were known to be completely evaluated, and such evaluation 
will surely prove to be worth regarding a stone former since the 
underlying problem can be identified and easily tackled. On the other 
hand, where complete metabolic evaluation is not ordered, it may not 
be possible to explain the major abnormalities present in the patients 
and the cause for such an abnormality. Thus, it is strongly suggested 
that the patients presenting with staghorn, multiple, or recurrent calculi 
must be subject to complete metabolic evaluation and strategies must 
be undertaken to implement the same in all major health-care centers.
Fig. 12: Plot of urine volume in n=55
Fig. 13: Plot of urine pH in n=55
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CONCLUSION
Out of the 100 patients included in the study, only 55 patients were 
subject to metabolic evaluation. The rest 45 patients were given 
proper treatment, mainly URS, ESWL, PCNL, and a combination of URS 
and ESWL/PCNL, and they left the hospital in a stable condition. The 
reason for not performing the metabolic evaluation in the 45% patients 
can be multifactorial. It might be because of poor patient compliance 
due to low economic status, to avoid unnecessary evaluation cost, or 
undervaluation as the patients did not come for further follow-up.
Out of the 55 patients evaluated, the metabolic abnormality was observed 
in 23 patients (41.8%). Once there is any metabolic abnormality, there 
is chance for the individual to get stones in both the kidneys. The FTSF 
who may be diagnosed with bilateral or multiple stones should also be 
metabolically evaluated, to prevent further recurrence.
As per the study, hyperuricemia/uricosuria (29.1%) was found to be 
the major metabolic abnormality in the evaluated patients (n=55) 
followed by hypercalcemia/calciuria (7.3%). A low urine volume and 
acidic urine pH were also considered to be contributing risk factors. 
Even though non-vegetarian diet and low water intake were major 
risk factors for renal stones, the statistical method used did not show 
any significance. This might be due to the small sample size used in 
the study which was not sufficient for an accurate result. This only 
shows the pattern of stone formation in the patients studied and not 
for the entire renal stone population. Abnormality in uric acid level 
was statistically significant (p=0.000). Abnormal calcium (p=0.002) 
and creatinine (p=0.040) levels were also statistically significant. Even 
though there is no direct correlation between increased RBS and renal 
stones, in this study, it showed statistical significance, and thus, it might 
be associated with hyperuricemia in stone patients. There might be 
an indirect relationship between hyperglycemia and hyperuricemia 
in individuals, and hypothetically, most of the diabetic patients had 
hyperuricemia that explains stone incidence. Thus, any abnormality in 
RBS levels of an individual should also be treated to avoid stones as 
well as other critical medical conditions such as diabetes and metabolic 
syndrome.
For the rest of the patients (58.2%), who did not have any metabolic 
abnormality, the major risk factors were assumed to be non-vegetarian 
diet and low water intake. The hot climate of this geographical region is 
also a possible contributor to stone formation and recurrence. Thus, a 
proper diet recommendation is to be provided, and the patient should 
be explained about the importance of drinking adequate water, i.e. a 
stone former must drink more than 3 liters of water a day and with 
physical activity and hot climate, the intake should be increased.
It was reported that hyperuricemia/uricosuria was the major 
metabolic abnormality in this geographical region, followed by acidic 
urine pH, low urine volume, and a small percentage of people showed 
hypercalcemia/calciuria. It was also reported that renal stone disease 
was not related to any age group, though in this population studied, it 
was more common in the age group of 51-60 and the mean age of stone 
formation was observed to be 45.71±14.20. It occurs in both gender, 
but the incidence was high in males than in females. Thus, in this study, 
renal stone formation showed no association with the patient’s age and 
gender. The metabolic abnormalities were corrected by administration 
of suitable medications and proper patient care. Proper treatment 
was provided in the hospital to ensure that the patients left in a stable 
and healthy condition, along with patient education so as to reduce 
the recurrence of stones as well as economic costs. Patients should 
be taught about the role of diet and water intake in the prevention of 
metabolic abnormalities and thereby prevention of renal stones. The 
patients were suggested to go with very high fluid intake along with 
reduction of amount of protein and salt in the diet. Finally, it is suggested 
that those presenting with renal stones should be robustly evaluated so 
as to improve the quality of treatment as well as the quality of life of 
the patients.
In conclusion, it was finalized that any patient with multiple or 
recurrent stones will surely have one or more metabolic abnormality 
that can be treated by providing good medical care. It was also observed 
that stone patients were under evaluated in the hospital, which is either 
due to the patients low financial background or because these patients 
did not return for further follow-up. Implementation of metabolic 
evaluation in patients presenting with staghorn, multiple, or recurrent 
stones is compulsory, and it will definitely help in preventing further 
recurrences. Long-term studies to evaluate stone patients for metabolic 
abnormalities should be taken into account so as to significantly reduce 
the prevalence and incidence of stones in the general population. 
Improved awareness about modifiable risk factors of renal stones 
among both general population and the health-care providers is very 
necessary, and this can be achieved by providing proper education 
regarding the same. This helps in improving the general health and 
decrease morbidity and mortality and even the cost associated with the 
renal stone disease.
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